Eagle Pharmaceuticals
EGRX
#10505
Rank
A$4.31 M
Marketcap
A$0.33
Share price
46.67%
Change (1 day)
-65.44%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$4.31 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of A$4.31 Million. This makes Eagle Pharmaceuticals the world's 10505th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$4.31 M-62.38%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
A$4.31 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$751.72 B 17,440,775.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$149.83 B 3,476,203.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$394.71 B 9,157,677.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
A$52.64 B 1,221,308.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$266.52 B 6,183,679.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.452 T 33,692,065.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$166.78 B 3,869,588.03%๐Ÿ‡บ๐Ÿ‡ธ USA